NCT04039503 A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin Status COMPLETED Phase PHASE3
NCT04004988 A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants Status COMPLETED Phase PHASE1
NCT03987919 A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT03954834 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone Status COMPLETED Phase PHASE3
NCT03951753 A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE1
NCT03940742 A Study of Tirzepatide in Participants With Impaired Liver Function Status COMPLETED Phase PHASE1
NCT03882970 A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT03861052 A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT03861039 A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT03730662 A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk Status COMPLETED Phase PHASE3
NCT03482024 A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function Status COMPLETED Phase PHASE1
NCT03322631 A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT03311724 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT03131687 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02759107 A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM) Status COMPLETED Phase PHASE1